DE3232831A1 - Arzneimittel - Google Patents

Arzneimittel

Info

Publication number
DE3232831A1
DE3232831A1 DE19823232831 DE3232831A DE3232831A1 DE 3232831 A1 DE3232831 A1 DE 3232831A1 DE 19823232831 DE19823232831 DE 19823232831 DE 3232831 A DE3232831 A DE 3232831A DE 3232831 A1 DE3232831 A1 DE 3232831A1
Authority
DE
Germany
Prior art keywords
phenoxy
methanol
triazole
propyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19823232831
Other languages
German (de)
English (en)
Inventor
Roy Thomas Hitchin Hertfordshire Brittain
Barry John Tewin Wood Hertfordshire Price
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE3232831A1 publication Critical patent/DE3232831A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19823232831 1981-09-04 1982-09-03 Arzneimittel Withdrawn DE3232831A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8126787 1981-09-04

Publications (1)

Publication Number Publication Date
DE3232831A1 true DE3232831A1 (de) 1983-03-24

Family

ID=10524317

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19823232831 Withdrawn DE3232831A1 (de) 1981-09-04 1982-09-03 Arzneimittel

Country Status (18)

Country Link
JP (1) JPS5855421A (cg-RX-API-DMAC7.html)
KR (1) KR840001276A (cg-RX-API-DMAC7.html)
AU (1) AU8799882A (cg-RX-API-DMAC7.html)
BE (1) BE894286A (cg-RX-API-DMAC7.html)
DE (1) DE3232831A1 (cg-RX-API-DMAC7.html)
DK (1) DK396582A (cg-RX-API-DMAC7.html)
FI (1) FI823041A7 (cg-RX-API-DMAC7.html)
FR (1) FR2512343A1 (cg-RX-API-DMAC7.html)
GB (1) GB2105588B (cg-RX-API-DMAC7.html)
GR (1) GR76433B (cg-RX-API-DMAC7.html)
IL (1) IL66709A0 (cg-RX-API-DMAC7.html)
IT (1) IT8249072A0 (cg-RX-API-DMAC7.html)
LU (1) LU84364A1 (cg-RX-API-DMAC7.html)
NL (1) NL8203456A (cg-RX-API-DMAC7.html)
PT (1) PT75504A (cg-RX-API-DMAC7.html)
SE (1) SE8205035L (cg-RX-API-DMAC7.html)
ZA (1) ZA826479B (cg-RX-API-DMAC7.html)
ZW (1) ZW18582A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
GB8805268D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
US20110301116A1 (en) * 2008-12-04 2011-12-08 The University Of Tokyo Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI68395C (fi) * 1979-03-02 1985-09-10 Glaxo Group Ltd Foerfarande foer framstaellning av farmakologiskt verksamma trazolfoereningar
DK446980A (da) * 1979-10-22 1981-04-23 Glaxo Group Ltd R fremgangsmaade til fremstilling af heterocycliske forbindelse

Also Published As

Publication number Publication date
IL66709A0 (en) 1982-12-31
GB2105588A (en) 1983-03-30
LU84364A1 (fr) 1984-04-24
KR840001276A (ko) 1984-04-30
FR2512343A1 (fr) 1983-03-11
FI823041L (fi) 1983-03-05
GR76433B (cg-RX-API-DMAC7.html) 1984-08-10
BE894286A (fr) 1983-03-02
DK396582A (da) 1983-03-05
GB2105588B (en) 1984-07-18
SE8205035D0 (sv) 1982-09-03
SE8205035L (sv) 1983-03-05
JPS5855421A (ja) 1983-04-01
NL8203456A (nl) 1983-04-05
ZA826479B (en) 1984-04-25
FI823041A0 (fi) 1982-09-03
IT8249072A0 (it) 1982-09-03
FI823041A7 (fi) 1983-03-05
AU8799882A (en) 1983-03-10
ZW18582A1 (en) 1984-03-28
PT75504A (en) 1982-10-01

Similar Documents

Publication Publication Date Title
US4066756A (en) Therapeutic compositions of 1,3-bis(2-carboxychromon-5-yloxyl)propan-2-ol and aspirin or indomethacin
DE60019329T2 (de) Neue zusammensetzung auf basis von einem thiazolidindion und metformin und verwendung
DE60032749T2 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
AT401468B (de) Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat
EP0386440B1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
DE3650488T2 (de) Verwendung eines Tetrahydrocarbazolonderivates zur Herstellung von Arzneimitteln
DE60019116T2 (de) Neue omeprazole und (s)-omeprazole zusammensetzung
DE69530759T2 (de) Filmbeschichtete tablette, die paracetamol und domperidone enthält
DE3627423A1 (de) Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
WO1994013287A1 (de) Verwendung von 2-amino-6-a-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) als arzneimittel mit antidepressiver wirkung
DE3346525C2 (de) Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-glycero-3-phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich
WO1997034600A1 (de) Kombinationspräparat, enthaltend 5-methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid und n-(4-trifluormethylphenyl)-2-cyan-3-hydroxycrotonsäureamid
DE69003213T2 (de) Imidazol-Derivate als Histamin-H3-Agonisten.
DE3343934A1 (de) M-chlor-(alpha)-tert.-butylaminopropiophenon und seine verwendung zur senkung des cholesterolspiegels
AT405134B (de) Furanderivate enthaltende pharmazeutische präparate
EP0169465A2 (de) Kombinationspräparat aus Pyrimido-pyrimidinen und O-Acetylsalicylsäure bzw. deren pharmakologisch verträglichen Salzen und dessen Verwendung
EP0548103B1 (de) Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
DE3232831A1 (de) Arzneimittel
DE2708520C2 (cg-RX-API-DMAC7.html)
CH667592A5 (de) 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen.
DE3906883C2 (de) Pharmazeutisches Präparat aus einem Carbazolon und Dexamethason sowie seine Verwendung
DE3232830A1 (de) Arzneimittel
AT408718B (de) Natriumvalproat-granulat mit verringerter hygroskopizität
DE3906884A1 (de) Pharmazeutisches praeparat
DE3530780C2 (de) Neue pharmazeutische Verwendung von 5-(3-n-Butyloxalylaminophenyl)-tetrazol

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee